Feasibility of Using Daily Home High-Flow Nasal Therapy in COPD Patients Following a Recent COPD Hospitalization
Author(s) -
Gerard J. Criner,
Lii-Yoong H Criner,
Sheril A George,
Jiji Thomas,
Michael R. Jacobs
Publication year - 2021
Publication title -
chronic obstructive pulmonary diseases journal of the copd foundation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.039
H-Index - 9
ISSN - 2372-952X
DOI - 10.15326/jcopdf.2021.0236
Subject(s) - medicine , copd , exacerbation , quality of life (healthcare) , obstructive lung disease , clinical trial , physical therapy , emergency medicine , nursing
High-flow nasal therapy (HFNT) has beneficial effects in patients hospitalized with acute hypoxemic respiratory failure. HFNT has not been extensively studied following hospitalization for an acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom